{"id":"W4256191981","doi":"10.1182/blood.v116.21.3437.3437","title":"Comparison of Adherence Between Nilotinib and Dasatinib as Second-Line Therapies In Chronic Myeloid Leukemia.","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Nilotinib; Dasatinib; Medicine; Myeloid leukemia; Imatinib; Internal medicine; Tyrosine-kinase inhibitor; Medical prescription; Imatinib mesylate; Tyrosine kinase; Oncology; Pharmacology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00657598,0.0002483376,0.0008287028,0.0008043296,0.0002413363,0.0008541169,0.0005761324,0.0006567624,0.001154021],"category_scores_gemma":[0.01482215,0.0002331454,0.001575634,0.001424949,0.0002630015,0.0005898316,0.0006428356,0.0007894269,0.0001295925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001074668,"about_ca_system_score_gemma":0.0006496054,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002463839,"about_ca_topic_score_gemma":0.002318772,"domain_scores_codex":[0.9910813,0.004828691,0.001355445,0.0008346672,0.00161939,0.0002804649],"domain_scores_gemma":[0.9842489,0.005536104,0.008208126,0.0005377543,0.0007036359,0.0007653675],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.061046,0.001380027,0.903466,0.0008208835,0.005007162,0.00006352949,0.0003405477,0.0009888024,0.0004568761,0.0002236447,0.0007125062,0.02549393],"study_design_scores_gemma":[0.003514769,0.01438295,0.9753725,0.0001127477,0.001462631,0.0001663004,0.0002814071,0.003180019,0.0003522051,0.0001030616,0.001041775,0.00002967826],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996566,0.001479977,0.0001016908,0.00008939993,0.0000197796,0.00009307015,0.001189492,0.000004583481,0.0004560238],"genre_scores_gemma":[0.9985978,0.000255415,0.0001028439,0.00004979613,0.00001873536,0.00006380014,0.0008493064,0.000001474305,0.00006100894],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00657598,"threshold_uncertainty_score":0.03477758,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03324211498638943,"score_gpt":0.3303353564827807,"score_spread":0.2970932414963913,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}